borderline significancep = 0.053
When analyzing survival in all patients (stages I–IV), a borderline significance was observed (HR = 0.87, p = 0.053; median survival in the low-expression cohort = 19.4 months, median survival in the high-expression cohort = 21 months) ( Figure 1 B).